Cerus reported $-1.45M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Cerus USD -1.45M 488K Dec/2024
GRIFOLS EUR 428M 179M Jun/2026
Haemonetics USD 57.46M 80.48M Jun/2026
Neogen USD 3.1M 6.4M Mar/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Quidel USD -15.3M 12.1M Jun/2026
STAAR Surgical USD 10.1M 7.3M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Utah Medical Products USD 2.56M 124K Mar/2026